Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

Clinicopathological features of the rare form of Creutzfeldt-Jakob disease in R208H-V129V PRNP carrier.

Tiple D, Poleggi A, Mellina V, Morocutti A, Brusa L, Iani C, Colaizzo E, Vaianella L, Baiardi S, Ladogana A, Parchi P, Pocchiari M.

Acta Neuropathol Commun. 2019 Mar 21;7(1):47. doi: 10.1186/s40478-019-0699-1. No abstract available.

2.

Is there a correlation between urological and cardiovascular dysfunction in Parkinson's disease?

Brusa L, Rocchi C, Ponzo V, Stanzione P, Finazzi E, Attanasio A.

Funct Neurol. 2018 Oct/Dec;33(4):225-228.

PMID:
30663970
3.

Does fatigue in Parkinson's disease correlate with autonomic nervous system dysfunction?

Olivola E, Brusa L, Rocchi C, Schillaci O, Liguori C, Cerroni R, Pierantozzi M, Chiaravalloti A, Stefani A, Stocchi F.

Neurol Sci. 2018 Dec;39(12):2169-2174. doi: 10.1007/s10072-018-3569-x. Epub 2018 Sep 25.

PMID:
30255487
4.

Dysfunctional inhibitory control in Parkinson's disease patients with levodopa-induced dyskinesias.

Picazio S, Ponzo V, Caltagirone C, Brusa L, Koch G.

J Neurol. 2018 Sep;265(9):2088-2096. doi: 10.1007/s00415-018-8945-1. Epub 2018 Jul 6.

PMID:
29980853
5.

Reply Letter to "Does motor cortex plasticity depend on the type of mutation in the LRRK2 gene?"

Lorenzo FD, Ponzo V, Brusa L, Caltagirone C, Koch G.

Mov Disord. 2017 Jun;32(6):949. doi: 10.1002/mds.27011. Epub 2017 Apr 17. No abstract available.

PMID:
28419651
6.

Rotigotine Effects on Bladder Function in Patients with Parkinson's Disease.

Brusa L, Petta F, Farullo G, Iacovelli V, Ponzo V, Iani C, Stanzione P, Agró EF.

Mov Disord Clin Pract. 2017 Apr 19;4(4):586-589. doi: 10.1002/mdc3.12488. eCollection 2017 Jul-Aug.

7.

Impaired intracortical transmission in G2019S leucine rich-repeat kinase Parkinson patients.

Ponzo V, Di Lorenzo F, Brusa L, Schirinzi T, Battistini S, Ricci C, Sambucci M, Caltagirone C, Koch G.

Mov Disord. 2017 May;32(5):750-756. doi: 10.1002/mds.26931. Epub 2017 Feb 10.

PMID:
28186666
8.

Genetic analysis of CHCHD2 and CHCHD10 in Italian patients with Parkinson's disease.

Rubino E, Brusa L, Zhang M, Boschi S, Govone F, Vacca A, Gai A, Pinessi L, Lopiano L, Rogaeva E, Rainero I.

Neurobiol Aging. 2017 May;53:193.e7-193.e8. doi: 10.1016/j.neurobiolaging.2016.12.027. Epub 2017 Jan 5.

PMID:
28108040
9.

Subthalamic stimulation and levodopa modulate cortical reactivity in Parkinson's patients.

Casula EP, Stampanoni Bassi M, Pellicciari MC, Ponzo V, Veniero D, Peppe A, Brusa L, Stanzione P, Caltagirone C, Stefani A, Koch G.

Parkinsonism Relat Disord. 2017 Jan;34:31-37. doi: 10.1016/j.parkreldis.2016.10.009. Epub 2016 Oct 17.

PMID:
27771287
10.

Pathological Gambling in Parkinson's disease patients: Dopaminergic medication or personality traits fault?

Brusa L, Pavino V, Massimetti MC, Ceravolo R, Stefani S, Stanzione P.

J Neurol Sci. 2016 Jul 15;366:167-170. doi: 10.1016/j.jns.2016.03.032. Epub 2016 Apr 7.

PMID:
27288799
11.

Total arsenic in selected food samples from Argentina: Estimation of their contribution to inorganic arsenic dietary intake.

Sigrist M, Hilbe N, Brusa L, Campagnoli D, Beldoménico H.

Food Chem. 2016 Nov 1;210:96-101. doi: 10.1016/j.foodchem.2016.04.072. Epub 2016 Apr 20.

PMID:
27211625
12.

Altered inhibitory interaction among inferior frontal and motor cortex in l-dopa-induced dyskinesias.

Ponzo V, Picazio S, Benussi A, Di Lorenzo F, Brusa L, Caltagirone C, Koch G.

Mov Disord. 2016 May;31(5):755-9. doi: 10.1002/mds.26520. Epub 2016 Feb 10.

PMID:
26861941
13.

An investigation of hearing impairment in de-novo Parkinson's disease patients: A preliminary study.

Pisani V, Sisto R, Moleti A, Di Mauro R, Pisani A, Brusa L, Altavista MC, Stanzione P, Di Girolamo S.

Parkinsonism Relat Disord. 2015 Aug;21(8):987-91. doi: 10.1016/j.parkreldis.2015.06.007. Epub 2015 Jun 9.

PMID:
26071125
14.

Wearing-off detection in clinical practice: the wearing off real practice key (WORK-PD) study in Parkinson's disease.

Altavista MC, Cassetta E, Brusa L, Viselli F, Denaro A, Ventriglia M, Pasqualetti P, Peppe A.

Parkinsonism Relat Disord. 2015 Feb;21(2):95-100. doi: 10.1016/j.parkreldis.2014.11.002. Epub 2014 Nov 14.

PMID:
25443558
15.

A network centred on the inferior frontal cortex is critically involved in levodopa-induced dyskinesias.

Cerasa A, Koch G, Donzuso G, Mangone G, Morelli M, Brusa L, Stampanoni Bassi M, Ponzo V, Picazio S, Passamonti L, Salsone M, Augimeri A, Caltagirone C, Quattrone A.

Brain. 2015 Feb;138(Pt 2):414-27. doi: 10.1093/brain/awu329. Epub 2014 Nov 19.

PMID:
25414038
16.

Effects of two weeks of cerebellar theta burst stimulation in cervical dystonia patients.

Koch G, Porcacchia P, Ponzo V, Carrillo F, Cáceres-Redondo MT, Brusa L, Desiato MT, Arciprete F, Di Lorenzo F, Pisani A, Caltagirone C, Palomar FJ, Mir P.

Brain Stimul. 2014 Jul-Aug;7(4):564-72. doi: 10.1016/j.brs.2014.05.002. Epub 2014 May 9.

PMID:
24881805
17.

Rasagiline effect on bladder disturbances in early mild Parkinson's disease patients.

Brusa L, Musco S, Bernardi G, Iani C, Pierantozzi M, Stanzione P, Stefani A, Finazzi Agro' E.

Parkinsonism Relat Disord. 2014 Aug;20(8):931-2. doi: 10.1016/j.parkreldis.2014.04.020. Epub 2014 Apr 28. No abstract available.

PMID:
24861661
18.

Tetrabenazine improves levodopa-induced peak-dose dyskinesias in patients with Parkinson's disease.

Brusa L, Orlacchio A, Stefani A, Galati S, Pierantozzi M, Iani C, Mercuri NB.

Funct Neurol. 2013 Apr-May;28(2):101-5. doi: 10.11138/FNeur/2013.28.2.101.

19.

Theta burst stimulation modulates cerebellar-cortical connectivity in patients with progressive supranuclear palsy.

Brusa L, Ponzo V, Mastropasqua C, Picazio S, Bonnì S, Di Lorenzo F, Iani C, Stefani A, Stanzione P, Caltagirone C, Bozzali M, Koch G.

Brain Stimul. 2014 Jan-Feb;7(1):29-35. doi: 10.1016/j.brs.2013.07.003. Epub 2013 Jul 26.

PMID:
23928103
20.

The effect of dopamine agonists on cognitive functions in non-demented early-mild Parkinson's disease patients.

Brusa L, Pavino V, Massimetti MC, Bove R, Iani C, Stanzione P.

Funct Neurol. 2013 Jan-Mar;28(1):13-7.

21.

Determination of selenium in selected food samples from Argentina and estimation of their contribution to the Se dietary intake.

Sigrist M, Brusa L, Campagnoli D, Beldoménico H.

Food Chem. 2012 Oct 15;134(4):1932-7. doi: 10.1016/j.foodchem.2012.03.116. Epub 2012 Apr 4.

PMID:
23442641
22.

Multiple myeloma and paget disease with abnormal skull lesions and intracranial hypertension.

Caravita T, Siniscalchi A, Montinaro E, Bove R, Zaccagnini M, De Pascalis D, Morocutti A, Brusa L, Arciprete F, Cupini M, Perrotti A, Palma E, Fratoni S, De Simone R, Iani C, de Fabritiis P.

Mediterr J Hematol Infect Dis. 2012;4(1):e2012068. doi: 10.4084/MJHID.2012.068. Epub 2012 Nov 5.

23.

CSF and clinical hallmarks of subcortical dementias: focus on DLB and PDD.

Stefani A, Brusa L, Olivola E, Pierantozzi M, Martorana A.

J Neural Transm (Vienna). 2012 Jul;119(7):861-75. doi: 10.1007/s00702-012-0820-0. Epub 2012 May 24. Review.

PMID:
22622365
24.

Metabolic changes induced by theta burst stimulation of the cerebellum in dyskinetic Parkinson's disease patients.

Brusa L, Ceravolo R, Kiferle L, Monteleone F, Iani C, Schillaci O, Stanzione P, Koch G.

Parkinsonism Relat Disord. 2012 Jan;18(1):59-62. doi: 10.1016/j.parkreldis.2011.08.019. Epub 2011 Sep 15.

PMID:
21920793
25.

Low frequency stimulation of the nucleus tegmenti pedunculopontini increases cortical metabolism in parkinsonian patients.

Ceravolo R, Brusa L, Galati S, Volterrani D, Peppe A, Siciliano G, Pierantozzi M, Moschella V, Bonuccelli U, Stanzione P, Stefani A.

Eur J Neurol. 2011 Jun;18(6):842-9. doi: 10.1111/j.1468-1331.2010.03254.x. Epub 2010 Nov 19.

PMID:
21087362
26.
27.

Bladder symptoms assessed with overactive bladder questionnaire in Parkinson's disease.

Iacovelli E, Gilio F, Meco G, Fattapposta F, Vanacore N, Brusa L, Giacomelli E, Gabriele M, Rubino A, Locuratolo N, Iani C, Pichiorri F, Colosimo C, Carbone A, Palleschi G, Inghilleri M.

Mov Disord. 2010 Jul 15;25(9):1203-9. doi: 10.1002/mds.23093.

PMID:
20310046
28.

Pathological gambling from dopamine agonist and deep brain stimulation of the nucleus tegmenti pedunculopontine.

Stefani A, Galati S, Brusa L, Pierantozzi M, Peppe A, Stanzione P.

BMJ Case Rep. 2010 Nov 18;2010. pii: bcr0220102774. doi: 10.1136/bcr.02.2010.2774.

29.

Olfactory dysfunction in Parkinsonism caused by PINK1 mutations.

Ferraris A, Ialongo T, Passali GC, Pellecchia MT, Brusa L, Laruffa M, Guidubaldi A, Paludetti G, Albanese A, Barone P, Dallapiccola B, Valente EM, Bentivoglio AR.

Mov Disord. 2009 Dec 15;24(16):2350-7. doi: 10.1002/mds.22816.

PMID:
19890973
30.

Non-motor functions in parkinsonian patients implanted in the pedunculopontine nucleus: focus on sleep and cognitive domains.

Alessandro S, Ceravolo R, Brusa L, Pierantozzi M, Costa A, Galati S, Placidi F, Romigi A, Iani C, Marzetti F, Peppe A.

J Neurol Sci. 2010 Feb 15;289(1-2):44-8. doi: 10.1016/j.jns.2009.08.017. Epub 2009 Sep 17. Review.

PMID:
19765737
31.

Implantation of the nucleus tegmenti pedunculopontini in a PSP-P patient: safe procedure, modest benefits.

Brusa L, Iani C, Ceravolo R, Galati S, Moschella V, Marzetti F, Stanzione P, Stefani A.

Mov Disord. 2009 Oct 15;24(13):2020-2. doi: 10.1002/mds.22706. No abstract available.

PMID:
19672983
32.

Cerebellar magnetic stimulation decreases levodopa-induced dyskinesias in Parkinson disease.

Koch G, Brusa L, Carrillo F, Lo Gerfo E, Torriero S, Oliveri M, Mir P, Caltagirone C, Stanzione P.

Neurology. 2009 Jul 14;73(2):113-9. doi: 10.1212/WNL.0b013e3181ad5387.

PMID:
19597133
33.

Treatment of the symptoms of Huntington's disease: preliminary results comparing aripiprazole and tetrabenazine.

Brusa L, Orlacchio A, Moschella V, Iani C, Bernardi G, Mercuri NB.

Mov Disord. 2009 Jan 15;24(1):126-9. doi: 10.1002/mds.22376.

PMID:
19170197
34.

Effects of inhibitory rTMS on bladder function in Parkinson's disease patients.

Brusa L, Finazzi Agrò E, Petta F, Sciobica F, Torriero S, Lo Gerfo E, Iani C, Stanzione P, Koch G.

Mov Disord. 2009 Feb 15;24(3):445-8. doi: 10.1002/mds.22434.

PMID:
19133657
35.

Correlation between changes in CSF dopamine turnover and development of dyskinesia in Parkinson's disease.

Lunardi G, Galati S, Tropepi D, Moschella V, Brusa L, Pierantozzi M, Stefani A, Rossi S, Fornai F, Fedele E, Stanzione P, Hainsworth AH, Pisani A.

Parkinsonism Relat Disord. 2009 Jun;15(5):383-9. doi: 10.1016/j.parkreldis.2008.10.001. Epub 2008 Nov 17.

PMID:
19010710
36.

Levodopa improves time-based prospective memory in Parkinson's disease.

Costa A, Peppe A, Brusa L, Caltagirone C, Gatto I, Carlesimo GA.

J Int Neuropsychol Soc. 2008 Jul;14(4):601-10. doi: 10.1017/S135561770808082X.

PMID:
18577289
37.

Sleep-wake cycle and effects of cabergoline monotherapy in de novo Parkinson's disease patients. An ambulatory polysomnographic study.

Placidi F, Izzi F, Romigi A, Stanzione P, Marciani MG, Brusa L, Sperli F, Galati S, Pasqualetti P, Pierantozzi M.

J Neurol. 2008 Jul;255(7):1032-7. doi: 10.1007/s00415-008-0836-4. Epub 2008 Jun 2.

PMID:
18500498
38.

Pedunculopontine nucleus stimulation influences REM sleep in Parkinson's disease.

Romigi A, Placidi F, Peppe A, Pierantozzi M, Izzi F, Brusa L, Galati S, Moschella V, Marciani MG, Mazzone P, Stanzione P, Stefani A.

Eur J Neurol. 2008 Jul;15(7):e64-5. doi: 10.1111/j.1468-1331.2008.02167.x. Epub 2008 May 15. No abstract available. Erratum in: Eur J Neurol. 2008 Jul;15(7):e57.

PMID:
18484989
39.

Dopaminergic modulation of prospective memory in Parkinson's disease.

Costa A, Peppe A, Brusa L, Caltagirone C, Gatto I, Carlesimo GA.

Behav Neurol. 2008;19(1-2):45-8.

40.

PINK1 heterozygous rare variants: prevalence, significance and phenotypic spectrum.

Marongiu R, Ferraris A, Ialongo T, Michiorri S, Soleti F, Ferrari F, Elia AE, Ghezzi D, Albanese A, Altavista MC, Antonini A, Barone P, Brusa L, Cortelli P, Martinelli P, Pellecchia MT, Pezzoli G, Scaglione C, Stanzione P, Tinazzi M, Zecchinelli A, Zeviani M, Cassetta E, Garavaglia B, Dallapiccola B, Bentivoglio AR, Valente EM; Italian PD Study Group.

Hum Mutat. 2008 Apr;29(4):565. doi: 10.1002/humu.20719.

PMID:
18330912
41.

Late onset sporadic Parkinson's disease caused by PINK1 mutations: clinical and functional study.

Gelmetti V, Ferraris A, Brusa L, Romano F, Lombardi F, Barzaghi C, Stanzione P, Garavaglia B, Dallapiccola B, Valente EM.

Mov Disord. 2008 Apr 30;23(6):881-5. doi: 10.1002/mds.21960.

PMID:
18307263
42.

Impaired reproduction of second but not millisecond time intervals in Parkinson's disease.

Koch G, Costa A, Brusa L, Peppe A, Gatto I, Torriero S, Gerfo EL, Salerno S, Oliveri M, Carlesimo GA, Caltagirone C.

Neuropsychologia. 2008 Apr;46(5):1305-13. doi: 10.1016/j.neuropsychologia.2007.12.005. Epub 2007 Dec 15.

PMID:
18215403
43.

Pedunculopontine nucleus deep brain stimulation changes spinal cord excitability in Parkinson's disease patients.

Pierantozzi M, Palmieri MG, Galati S, Stanzione P, Peppe A, Tropepi D, Brusa L, Pisani A, Moschella V, Marciani MG, Mazzone P, Stefani A.

J Neural Transm (Vienna). 2008 May;115(5):731-5. doi: 10.1007/s00702-007-0001-8. Epub 2008 Jan 15.

PMID:
18196202
44.

Acute vs chronic effects of l-dopa on bladder function in patients with mild Parkinson disease.

Brusa L, Petta F, Pisani A, Moschella V, Iani C, Stanzione P, Miano R, Finazzi-Agrò E.

Neurology. 2007 May 1;68(18):1455-9.

PMID:
17470746
45.

Repetitive transcranial magnetic stimulation of the motor cortex ameliorates spasticity in multiple sclerosis.

Centonze D, Koch G, Versace V, Mori F, Rossi S, Brusa L, Grossi K, Torelli F, Prosperetti C, Cervellino A, Marfia GA, Stanzione P, Marciani MG, Boffa L, Bernardi G.

Neurology. 2007 Mar 27;68(13):1045-50.

PMID:
17389310
46.

Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease.

Stefani A, Lozano AM, Peppe A, Stanzione P, Galati S, Tropepi D, Pierantozzi M, Brusa L, Scarnati E, Mazzone P.

Brain. 2007 Jun;130(Pt 6):1596-607. Epub 2007 Jan 24.

PMID:
17251240
47.

Deep brain stimulation in Parkinson's disease patients: biochemical evidence.

Stefani A, Fedele E, Galati S, Raiteri M, Pepicelli O, Brusa L, Pierantozzi M, Peppe A, Pisani A, Gattoni G, Hainsworth AH, Bernardi G, Stanzione P, Mazzone P.

J Neural Transm Suppl. 2006;(70):401-8.

PMID:
17017559
48.

Low frequency rTMS of the SMA transiently ameliorates peak-dose LID in Parkinson's disease.

Brusa L, Versace V, Koch G, Iani C, Stanzione P, Bernardi G, Centonze D.

Clin Neurophysiol. 2006 Sep;117(9):1917-21. Epub 2006 Aug 1.

PMID:
16887383
49.

Biochemical and electrophysiological changes of substantia nigra pars reticulata driven by subthalamic stimulation in patients with Parkinson's disease.

Galati S, Mazzone P, Fedele E, Pisani A, Peppe A, Pierantozzi M, Brusa L, Tropepi D, Moschella V, Raiteri M, Stanzione P, Bernardi G, Stefani A.

Eur J Neurosci. 2006 Jun;23(11):2923-8.

PMID:
16819981
50.

Bilateral Implantation of Centromedian-Parafascicularis Complex and GPi: A New Combination of Unconventional Targets for Deep Brain Stimulation in Severe Parkinson Disease.

Mazzone P, Stocchi F, Galati S, Insola A, Altibrandi MG, Modugno N, Tropepi D, Brusa L, Stefani A.

Neuromodulation. 2006 Jul;9(3):221-8. doi: 10.1111/j.1525-1403.2006.00063.x.

PMID:
22151710

Supplemental Content

Support Center